Systemic delivery of the interleukin-1 receptor antagonist protein using a new strategy of direct adenoviral-mediated gene transfer to skeletal muscle capillary endothelium in the isolated rat hindlimb

Human Gene Therapy

Volumn 7, Issue 15, 1996, Pages 1795-1802

  Welling, Theodore H ^a   Davidson, Beverly L ^b   Zelenock, Jennifer A ^a   Stanley, James C ^a   Gordon, David ^a   Roessler, Blake J ^a   Messina, Louis M ^c,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE PLACENTA ISOENZYME; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; RECOMBINANT PROTEIN;

ADENOVIRUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY ENDOTHELIUM; CONTROLLED STUDY; EXPRESSION VECTOR; GASTROCNEMIUS MUSCLE; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HINDLIMB; IMMUNE RESPONSE; INFLAMMATION; LIVER INJURY; LUNG INJURY; MALE; MARKER GENE; MUSCLE NECROSIS; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SKELETAL MUSCLE; TRANSGENE;

ADENOVIRIDAE; ANIMALIA;

EID: 0029856820     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1996.7.15-1795     Document Type: Article

References (30)

1. ASCADI, G., AGNES, J., MASSIE, B., SIMONEAU, M., HOLLAND, P., BLASCHUK, K., and KARPARTI, G. (1994). A differential efficiency of adenovirus-medicated in vivo gene transfer into skeletal muscles of different maturity. Hum. Mol. Genet. 3, 579-584.
2. BULL, H.A., RUSTIN, M.H.A., SPAULL, J., COHEN, J., WILSON-JONES, E., and DOWD, P.M. (1990). Pro-inflammatory mediators induce sustained release of prostaglandin E2 from human dermal microvascular endothelial cells. Br. J. Derm. 122, 153-164.
3. CARLSON, B.M., SHEPARD, B., and KOMOROWSKI, T.E. (1990). A histological study of local anesthetic-induced muscle degeneration and regeneration in the monkey. J. Orthop. Res. 8, 485-494.
4. DAVIDSON, B.L, DORAN, S.E., SHEWACH, D.S., LATTA, J.M., HARTMAN, J.W., and ROESSLER, B.J. (1994). Expression of Escherichia coli β-galactosidase and rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer. Exp. Neurol. 125, 258-267.
5. DEVORE, J.L. (1991). Probability and Statistics for Engineering and the Sciences. (Brooks/Cole Publishing Co., Belmont, CA) 716 pp.
6. DHAWAN, J., PAN, L.C., PAVLATH, G.K., TRAVIS, M.A., LANCTOT, A.M., and BLAU, H.M. (1991). Systemic delivery of human growth hormone by injection of genetically engineered myoblasts. Science 254, 1509-1512.
7. DINARELLO, C.A. (1994). Interleukin-1. Adv. Pharmacol. 25, 21-51.
8. ENGELHARDT, J.F., YE, X., DORANZ, B., and WILSON, J.M. (1994). Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc. Natl. Acad. Sci. USA 91, 6196-6200.
9. FIELDS-BERRY, S.C., HALLIDAY, A.L., and CEPKO, C.L. (1992). A recombinant retrovirus encoding alkaline phosphatase confirms clonal boundary assignment in lineage analysis of murine retinal cells. Proc. Natl. Acad. Sci. USA 89, 693-697.
10. FISHER, C.J., DHAINAUT, J.A., OPAL, S.M., PRIBBLE, J.P., BALK, R.A., SLOTMAN, G.J., IBERTI, T.J., RACKOW, E.C., SHAPIRO, M.J., GREENMAN, R.L., REINES, H.D., SHELLY, M.P., THOMPSON, B.W., LABRECQUE, J.F., CATALANO, M.A., KNAUS, W.A., and SADOFF, J.C. (1994). Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. J. Am. Med. Assn. 271, 1836-1843.
11. GRANOWITZ, E.V., SANTOS, A.A., POUTSIAKA, D.D., CANNON, J.G., WILMORE, D.W., WOLFF, S.M., and DINARELLO, C.A. (1991). Production of interleukin-1-receptor antagonist during experimental endotoxaemia. Lancet 338, 1423-1424.
12. GUYTON, A.C. (1991). Textbook of Medical Physiology. (W.B. Saunders Co., Philadelphia) 1014 pp.
13. HANSEN-SMITH, F.M., WATSON, L., LU, D.Y., and GOLDSTEIN, I. (1988). Griffonia simplicifolia I: Fluorescent tracer for microcirculatory vessels in nonperfused thin muscles and sectioned muscle. Microvasc. Res. 36, 199-215.
14. MAGEE, J.C., STONE, A.E., OLDHAM, K.T., and GUICE, K.S. (1994). Isolation, culture, and characterization of rat lung microvascular endothelial cells. Am. J. Physiol. 267, L433-L441.
15. MAIER, J.A.M., HLA, T., and MACIAG, T. (1990). Cyclooxygenase is an immediate-early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. 265, 10805-10808.
16. MATA M., JIN, C.F., and FINK, D.J. (1993). Axotomy increases CNTF receptor mRNA in rat spinal cord. Brain Res. 610, 162-165.
17. McCRAY, P.B., ARMSTRONG, K., ZABNER, J., MILLER, D.W., KORETZKY, G.A., COUTURE, L., ROBILLARD, J.E., SMITH, A.E., and WELSH, M.J. (1995). Adenoviral-mediated gene transfer to fetal pulmonary epithelia in vitro and in vivo. J. Clin. Invest. 95, 2620-2632.
18. MESSINA, L.M., PODRAZIK, R.M., WHITEHILL, T.A., EKHTERAE, D., BROTHERS, T.E., WILSON, J.M., BURKEL, W.E., and STANLEY, J.C. (1992). Adhesion and incorporation of lacZ-transduced endothelial cells into the intact capillary wall in the rat. Proc. Natl. Acad. Sci. USA 89, 12018-12022.
19. MESSINA, L.M., WELLING, T.H., SARKAR, R., SHANLEY, C.J., and STANLEY, J.C. (1995). Gene therapy for vascular disease. In Advances in Surgical Gene Therapy. D.K. Anderson, S.E. Raper, L.M. Messina, and J.S. Economou, eds. (World Medical Press, Cedar Knolls, NJ) pp. 27-60.
20. MILLAN, J.L. (1986). Molecular cloning and sequence analysis of human placental alkaline phosphatase. J. Biol. Chem. 261, 3112-3115.
21. MULLER, D.W., GORDON, D., SAN, H., YANG, Z., POMPILI, V.J., NABEL, G.J., and NABEL, E.G. (1994). Catheter-mediated pulmonary vascular gene transfer and expression. Circ. Res. 75, 1039-1049.
22. NABEL, E.G., and NABEL, G.J. (1994). Complex models for the study of gene function in cardiovascular biology. Annu. Rev. Physiol. 56, 741-761.
23. OOBOSHI, H., WELSH, M.J., RIOS, C.D., DAVIDSON, B.L., and HEISTAD, D.D. (1995). Adenovirus-mediated gene transfer to cerebral blood vessels in vivo. FASEB J. 9, 134a (Abstr.).
24. ROESSLER, B.J., HARTMAN, J.W., VALLANCE, D.K., LATTA, J.M., JANICH, S.L., and DAVIDSON, B.L. (1995). Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum. Gene Ther. 6, 307-316.
25. SIMON, R.H., ENGELHARDT, J.F., YANG, Y., ZEPEDA, M., WEBER-PENDLETON, S., GROSSMAN, M., and WILSON, J.M. (1993). Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: Toxicity study. Hum. Gene Ther. 4, 771-780.
26. TRIPATHY, S.K., GOLDWASSER, E., LU, M., BARR, E., and LEIDEN, J.M. (1994). Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc. Natl. Acad. Sci. USA 91, 11557-11561.
27. WAHL, S.M., ALLEN, J.B., DOUGHERTY, S., EVEQUOZ, V., PLUZNIK, D.H., WILDER, R.L., HAND, A.R., and WAHL, L.M. (1986). T lymphocyte-dependent evolution of bacterial cell wall-induced hepatic granulomas. J. Immunol. 137, 2199-2209.
28. YANG, Y., NUNES, F.A., BERENCSI, K., FURTH, E.E., GONZOL, E., and WILSON, J.M. (1994a). Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
29. YANG, Y., NUNES, F.A., BERENCSI, K., GONCZOL, E., ENGELHARDT, J.F., and WILSON, J.M. (1994b). Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis. Nature Genet. 7, 362-369.
30. YAO, S.N., FARJO, A., ROESSLER, B.J., DAVIDSON, B.L., and KURACHI, K. (1996). Adenovirus-mediated transfer of human factor IX gene in immunodeficient and normal mice: Evidence for persistence of viral genome and prolonged transgene expression in vivo. Viral Immunol. 9, 141-153.